Hepatitis B Virus DNA Quantitative Viral Load Test

Hepatitis B is an infection caused by the hepatitis B virus (HBV). It is often referred to as a “silent” liver disease, as many people may not experience any symptoms in the early stages of the disease. Symptoms of HBV infection may take up to 90 days to appear after exposure to the virus. After entering the body, HBV travels to the liver and multiplies there. Over time, it may lead to complications such as cirrhosis (scarring of the liver), liver failure, and hepatocellular carcinoma (liver cancer). An HBV infection of less than 6 months’ duration is known as an acute infection. If it persists for more than 6 months, it is known as a chronic infection.

Hepatitis B is contagious and can spread from person to person through direct contact with infected blood or other body fluids, such as semen, saliva and vaginal fluids; through the use of contaminated needles or medical equipment; and from an HBV-positive mother to her baby during childbirth.

The hepatitis B virus DNA quantitative viral load test is commonly done after HBV infection has been diagnosed to measure the amount of hepatitis B virus DNA (genetic material) in an infected person’s blood. It is also known as the hepatitis B viral load test or HBV DNA quantitative test. The HBV DNA quantitative viral load test can:

• Measure hepatitis B virus DNA levels in the blood.
• Help monitor disease progression in infected persons.
• Guide treatment decisions and help assess treatment response in infected persons.

The HBV DNA quantitative viral load test is recommended for people who may have following signs and symptoms of HBV infection:

• Acute stage:
• Weakness
• Fever
• Tiredness
• Loss of appetite
• Nausea and vomiting
• Abdominal pain
• Digestive disorders
• Dark urine
• Jaundice
• Elevated bilirubin levels.
• Chronic stage:
• Fatigue
• Jaundice
• Pain in the right upper side of the abdomen
• Abnormal liver enzymes
• Positive hepatitis B surface antigen result
• Visible damage to liver cells
• Scarring of the liver

The hepatitis B virus DNA quantitative viral load test may be recommended for individuals:

• Who are diagnosed with or suspected to have HBV infection to assess the amount of hepatitis B virus in their blood and their potential risk of transmitting the infection to others.
• With chronic HBV infection, to help guide treatment decisions.
• Receiving treatment for hepatitis B, to monitor their response to treatment or assess the development of resistance to antiviral medicines.
• With chronic hepatitis B who require regular monitoring of disease activity and progression.
• Who are pregnant and have HBV infection to assess the risk of transmission to the baby.
• Who are being monitored for HBV infection complications such as liver cirrhosis.
• With resolved or inactive infection who have a flare-up of disease activity (reactivation). Individuals at risk of reactivation include those who test positive for both anti-HBc and HBsAg, immunocompromised individuals, and some individuals with HIV.

The recommended frequency of HBV DNA quantitative viral load test is usually as follows:

The hepatitis B virus DNA quantitative viral load test measures the amount of hepatitis B virus (HBV) DNA in the blood in individuals with HBV infection and can help determine how quickly the virus is multiplying. Although it cannot diagnose any condition, it may help evaluate and manage the following when assessed along with other tests:

• Active HBV replication: A high viral load indicates the virus is multiplying actively.
• Chronic hepatitis B infection: A high viral load over time can help monitor disease activity.
• Progression of liver disease: A high viral load over time is usually associated with the risk of liver damage and conditions like cirrhosis or liver cancer.
• Response to antiviral treatment: A decrease in viral load during treatment indicates a good response to treatment.
• Reactivation of hepatitis B infection: Increased viral load in individuals with inactive HBV infection may indicate reactivation of the infection.

What to Expect Before the Hepatitis B Virus DNA Quantitative Viral Load Test

No fasting is required for a standalone Hepatitis B Virus DNA Quantitative Viral Load test. You can eat and drink normally. However, if it is part of a broader package that includes fasting tests, your doctor may advise fasting for 8-12 hours. Avoid strenuous exercise for 24 hours before the test, as intense physical activity can temporarily raise Hepatitis B Virus DNA Quantitative Viral Load levels and affect interpretation. Always inform your doctor about any ongoing medications.

What to Expect During the Blood Collection

A phlebotomist cleans the skin with an antiseptic, then places an elastic band around your upper arm to make the veins easier to access. A small needle is inserted into the vein; you may feel a brief pinch. Blood is collected into a labelled tube in under a minute.

What to Expect After the Hepatitis B Virus DNA Quantitative Viral Load Test

A small cotton swab and bandage are placed over the site to stop any minor bleeding. You can return to normal activities immediately. Minor bruising is normal and disappears quickly. If dizzy, sit and rest for a few minutes.

The hepatitis B virus quantitative PCR test determines only one parameter:

• The amount of hepatitis B virus genetic material (viral load) present in the blood.

The normal range for hepatitis B virus DNA normal range is as follows:

The following table will help you understand HBV DNA quantitative viral load test results:

Notes:

• The test results should be interpreted along with the results of other tests, including HBsAg, total anti-HBC, IgM anti-HBc, anti-HBs, and ALT.

Risks:

• This is a simple blood test that is usually safe. However, minor issues such as mild soreness, swelling, bleeding, or redness may occur at the needle insertion site. These issues usually subside quickly.

Limitations:

• The HBV DNA quantitative viral load test is not used in the preliminary diagnosis or confirmation of HBV infection.
• HBV quantitative viral load test results may be affected by human, technical, or equipment-related errors.
• Certain laboratory agents, biological material such as blood/urine, or other substances may interfere with the test results.

If you have an HBV infection, your doctor may recommend follow-up tests as follows:

• Hepatitis e antigen (HBeAg)
• Antibody to HBeAg (anti-HBe)
• Alanine aminotransferase (ALT)
• Aspartate aminotransferase (AST)
• Aspartate aminotransferase-to-platelet ratio index (APRI) test to assess the presence of liver fibrosis.
• FibroTest for detection of cirrhosis.
• Transient elastography (e.g., FibroScan), an ultrasound for detection of liver fibrosis.
• Ultrasound.
• MRI.
• CT scan.
• Liver biopsy